ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes.

Tri Juli Edi Tarigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.